We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
LANA2 antibody (CM-A807)
Kaposi's sarcoma-associated herpes virus LANA2
KSHV
KSHV
As low as
$528.40
In stock
Ref
00096459
LANA2 (latency-associated nuclear antigen) is an inhibitor of p53-induced transcription in reporter assays and may be an apoptosis antagonist.It is a nuclear protein associated with Kaposi's sarcoma-associated herpes virus (KSHV), or human herpes virus 8.It is found in abundance in the nuclei of cultured cells from KSHV-infected hematopoietic tissues, such as PEL (primary effusion lymphoma) and CD (multicentric Castleman's disease).It does not appear to be expressed in KS (Kaposi's sarcoma) lesions.
| ID Covalab | mab50074 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Monoclonal antibody |
| Clone | CM-A807 |
| Isotype | IgG1 / Kappa |
| Raised in | Mouse |
| Immunogen | Recombinant LANA2 fusion protein |
| Activity cross reaction | Reacts with human and murin Kaposi's sarcoma-associated herpes virus (KSHV) ~66-70 kDa LANA2 protein and shows no cross-reactivity to cellular proteins. |
| Species | HV |
| Labelling | None |
| Form | Purified (protein G) |
| Preservative | None |
| Storage instructions | Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Latency-associated nuclear antigen 2 (LANA2) |
| Applications | ELISA, IF, IHC, IP, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : - IHC : 1/10 to1/2000 - IF : 2 to 4 µg/ml - IP : 2 to 4 µg/ml - WB : 2 to 4 µg/ml |
Write Your Own Review